J2840 HCPCS Level II code: Injection, sebelipase alfa, 1 mg
J2840 is the HCPCS code for “Injection, sebelipase alfa, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2840Injection, sebelipase alfa, 1 mg
Short description: Inj sebelipase alfa 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J2840 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2017
Where J2840 sits
- 1J codesDrugs administered other than orally
- 2Active code J2840Injection, sebelipase alfa, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2840 mean?
J2840 is the HCPCS code for “Injection, sebelipase alfa, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2840?
CMS lists J2840’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2840
All J codesJ2802Injection, romiplostim, 1 microgramJ2804Injection, rifampin, 1 mgJ2805Injection, sincalide, 5 microgramsJ2806Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 microgramsJ2810Injection, theophylline, per 40 mgJ2820Injection, sargramostim (gm-csf), 50 mcgJ2850Injection, secretin, synthetic, human, 1 microgramJ2860Injection, siltuximab, 10 mgJ2865Injection, sulfamethoxazole 5 mg and trimethoprim 1 mgJ2910Injection, aurothioglucose, up to 50 mgJ2916Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mgJ2919Injection, methylprednisolone sodium succinate, 5 mg